Mass screening for hepatitis B and C in Southern Upper Egypt

BACKGROUND: It is well documented that Egypt has the highest prevalence of hepatitis C virus (HCV) infection in the world. The recent development of highly effective direct acting antiviral drugs (DAAs), has opened the possibility of treating and curing HCV infection in the Egyptian population on a...

Descripción completa

Detalles Bibliográficos
Autores principales: Soliman, Gamal, Elzalabany, Mahmoud S., Hassanein, Tarek, Miller, F. DeWolfe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805514/
https://www.ncbi.nlm.nih.gov/pubmed/31640639
http://dx.doi.org/10.1186/s12889-019-7640-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805514/
https://www.ncbi.nlm.nih.gov/pubmed/31640639
http://dx.doi.org/10.1186/s12889-019-7640-1

Ejemplares similares